- Home
- GDS vs EWTX Comparison
GDS vs EWTX Comparison
Compare GDS & EWTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDS
- EWTX
- Stock Information
- Founded
- GDS 2001
- EWTX 2017
- Country
- GDS China
- EWTX United States
- Employees
- GDS N/A
- EWTX N/A
- Industry
- GDS Computer Software: Programming Data Processing
- EWTX Biotechnology: Pharmaceutical Preparations
- Sector
- GDS Technology
- EWTX Health Care
- Exchange
- GDS Nasdaq
- EWTX Nasdaq
- Market Cap
- GDS 3.8B
- EWTX 3.3B
- IPO Year
- GDS 2016
- EWTX 2021
- Fundamental
- Price
- GDS $18.40
- EWTX $31.98
- Analyst Decision
- GDS Strong Buy
- EWTX Strong Buy
- Analyst Count
- GDS 4
- EWTX 5
- Target Price
- GDS $18.29
- EWTX $40.40
- AVG Volume (30 Days)
- GDS 1.6M
- EWTX 679.5K
- Earning Date
- GDS 11-19-2024
- EWTX 11-07-2024
- Dividend Yield
- GDS N/A
- EWTX N/A
- EPS Growth
- GDS N/A
- EWTX N/A
- EPS
- GDS N/A
- EWTX N/A
- Revenue
- GDS $1,564,750,016.00
- EWTX N/A
- Revenue This Year
- GDS $18.06
- EWTX N/A
- Revenue Next Year
- GDS $17.32
- EWTX N/A
- P/E Ratio
- GDS N/A
- EWTX N/A
- Revenue Growth
- GDS 11.95
- EWTX N/A
- 52 Week Low
- GDS $5.01
- EWTX $5.93
- 52 Week High
- GDS $24.74
- EWTX $38.12
- Technical
- Relative Strength Index (RSI)
- GDS 38.53
- EWTX 46.84
- Support Level
- GDS $17.21
- EWTX $29.82
- Resistance Level
- GDS $23.64
- EWTX $38.12
- Average True Range (ATR)
- GDS 1.49
- EWTX 1.93
- MACD
- GDS -0.54
- EWTX -0.70
- Stochastic Oscillator
- GDS 15.79
- EWTX 26.02
About GDS GDS Holdings Limited ADS
GDS Holdings started as an IT service provider in 2001 then moved to the data center business with its first self-developed data center opening in 2010. The company now develops and operates data centers in China and also builds, operates and transfers data centers for other clients. It offers colocation and managed services and mainly targets hyperscale cloud service customers who take large areas of its data centers or even whole data centers under long-term contracts. It has aggressively raised capital over the past four years for expansion. Its data centers are located predominantly in and around the Tier 1 cities in China and it has also started an expanding into Southeast Asia. GDS listed on the Nasdaq in 2016 and completed a secondary listing in Hong Kong in 2020.
About EWTX Edgewise Therapeutics Inc.
Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases.